Earlier this year, the government-appointed expert panel advised the Central Drugs Standard Control Organization (CDSCO), Indian drug regulator, to approve the import and marketing of Tirzepatide, provided the manufacturer conducts a phase IV clinical trial (post-marketing surveillance) and submits the protocol to CDSCO
However, under more extreme conditions such as: 1) inadequate intake of foodstuffs containing the antioxidants, 2) excessive intake of pro-oxidants, 3) exposure to noxious chemicals or ultraviolet light, 4) injury/wounds, and/or 5) intense exercise, especially eccentric exercise, the body's endogenous antioxidant system is not able to effectively remove excessive ROS production[2]
Get Chriss latest insights, premium protocols, and science breakdowns in video form
Even small temperature swings, repeated over days, chip away at its effectiveness in ways you cannot see, smell, or feel until your results start sliding backward